Impact of standard of care treatments and disease variables on outcomes in systemic lupus erythematosus trials: analysis from the Lupus Foundation of America Collective Data Analysis Initiative

OBJECTIVE: Most clinical trials for systemic lupus erythematosus (SLE) study the efficacy and safety of investigational agents added to variable background immunosuppressants, which has resulted in high response rates in patients treated with placebo plus standard of care (SOC) plus rescue measures....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Rheumatol
Autors principals: Kalunian, Kenneth Carekin, Kim, Mimi, Xie, Xianhong, Baskaran, Amrutha, Daly, Rossi Paola, Merrill, Joan Tenenbaum
Format: Artigo
Idioma:Inglês
Publicat: Medical Research and Education Association 2016
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5042268/
https://ncbi.nlm.nih.gov/pubmed/27708963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2015.0048
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars